Free Trial

MultiPlan (NYSE:MPLN) Stock Price Up 6.9% - Time to Buy?

MultiPlan logo with Medical background

MultiPlan Co. (NYSE:MPLN - Get Free Report)'s share price rose 6.9% during mid-day trading on Monday . The company traded as high as $45.94 and last traded at $45.43. Approximately 64,120 shares were traded during mid-day trading, a decline of 45% from the average daily volume of 117,409 shares. The stock had previously closed at $42.50.

MultiPlan Trading Up 2.6%

The business's fifty day moving average is $33.42 and its 200-day moving average is $24.29. The stock has a market capitalization of $801.60 million, a PE ratio of -0.52 and a beta of 0.13. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 21.73.

Institutional Investors Weigh In On MultiPlan

Large investors have recently made changes to their positions in the business. Public Employees Retirement System of Ohio boosted its stake in shares of MultiPlan by 75.2% in the fourth quarter. Public Employees Retirement System of Ohio now owns 2,477 shares of the company's stock valued at $37,000 after purchasing an additional 1,063 shares during the period. Northern Trust Corp boosted its stake in shares of MultiPlan by 5.5% in the fourth quarter. Northern Trust Corp now owns 14,335 shares of the company's stock valued at $212,000 after purchasing an additional 747 shares during the period. XTX Topco Ltd purchased a new position in shares of MultiPlan in the fourth quarter valued at $225,000. Jane Street Group LLC boosted its stake in shares of MultiPlan by 14.4% in the fourth quarter. Jane Street Group LLC now owns 19,985 shares of the company's stock valued at $295,000 after purchasing an additional 2,512 shares during the period. Finally, Walleye Capital LLC purchased a new position in shares of MultiPlan in the fourth quarter valued at $359,000. Institutional investors and hedge funds own 87.15% of the company's stock.

MultiPlan Company Profile

(Get Free Report)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.

Featured Stories

Should You Invest $1,000 in MultiPlan Right Now?

Before you consider MultiPlan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.

While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines